Works matching AU Ejlertsen, Bent

Results: 136
    1

    Timely germline BRCA testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective study.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 212, n. 2, p. 309, doi. 10.1007/s10549-025-07726-2
    By:
    • Kostov, Aleksandar M.;
    • Jensen, Maj-Britt;
    • Ejlertsen, Bent;
    • Thomassen, Mads;
    • Rossing, Maria;
    • Pedersen, Inge S.;
    • Petersen, Annabeth H.;
    • Christensen, Lise Lotte;
    • Wadt, Karin A. W.;
    • Berrocal-Almanza, Luis C.;
    • Miranda, Miguel;
    • Lænkholm, Anne-Vibeke
    Publication type:
    Article
    2
    3
    4

    Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.

    Published in:
    2021
    By:
    • Chan, Arlene;
    • Moy, Beverly;
    • Mansi, Janine;
    • Ejlertsen, Bent;
    • Holmes, Frankie Ann;
    • Chia, Stephen;
    • Iwata, Hiroji;
    • Gnant, Michael;
    • Loibl, Sibylle;
    • Barrios, Carlos H.;
    • Somali, Isil;
    • Smichkoska, Snezhana;
    • Martinez, Noelia;
    • Garcia-Alonso, Mirta;
    • Link, John S.;
    • Mayer, Ingrid A.;
    • Cold, Søren;
    • Morales Murillo, Serafin;
    • Senecal, Francis;
    • Inoue, Kenichi
    Publication type:
    journal article
    5
    6
    7
    8
    9
    10
    11

    Molecular cytogenetic analysis of a nontumorigenic human breast epithelial cell line that eventually turns tumorigenic: Validation of an analytical approach combining karyotyping, comparative genomic hybridization, chromosome painting, and single-locus fluorescence in situ hybridization

    Published in:
    Genes, Chromosomes & Cancer, 1997, v. 20, n. 1, p. 30, doi. 10.1002/(SICI)1098-2264(199709)20:1<30::AID-GCC5>3.0.CO;2-A
    By:
    • Nielsen, Kirsten Vang;
    • Niebuhr, Erik;
    • Ejlertsen, Bent;
    • Holstebroe, Søren;
    • Madsen, Mogens Winkel;
    • Briand, Per;
    • Mouridsen, Henning T.;
    • Bolund, Lars
    Publication type:
    Article
    12
    13
    14
    15
    16

    Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000–1.

    Published in:
    Acta Oncologica, 2020, v. 59, n. 7, p. 825, doi. 10.1080/0284186X.2020.1757149
    By:
    • Poikonen-Saksela, Paula;
    • Lindman, Henrik;
    • Sverrisdottir, Asgerdur;
    • Edlund, Per;
    • Villman, Kenneth;
    • Tennvall Nittby, Lena;
    • Cold, Søren;
    • Bechmann, Troels;
    • Stenbygaard, Lars;
    • Ejlertsen, Bent;
    • Andersson, Michael;
    • Blomqvist, Carl;
    • Bergh, Jonas;
    • Ahlgren, Johan
    Publication type:
    Article
    17
    18
    19
    20

    Is DBCG abreast of new developments?

    Published in:
    2018
    By:
    • Offersen, Birgitte V.;
    • Ejlertsen, Bent;
    • Balslev, Eva;
    • Flyger, Henrik;
    • Gerdes, Anne-Marie;
    • Hansen, Mads K.;
    • Hølmich, Lisbet R.;
    • Jensen, Maj-Britt;
    • Kristensen, Bent;
    • Laenkholm, Anne-Vibeke;
    • Mouridsen, Henning T.;
    • Nielsen, Mette H.;
    • Overgaard, Jens;
    • Tuxen, Malgorzata;
    • Vejborg, Ilse;
    • Christiansen, Peer
    Publication type:
    Editorial
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Safety of pregnancy following breast cancer.

    Published in:
    Acta Oncologica, 2009, v. 48, n. 3, p. 471, doi. 10.1080/02841860802546800
    By:
    • Kroman, Niels;
    • Ejlertsen, Bent;
    • Jensen, Maj-Britt;
    • Wohlfahrt, Jan
    Publication type:
    Article
    46
    47
    48
    49
    50